Some Kidney Cancer Patients Can Stop Combination Treatment After Two Years, Fox Chase Cancer Center Study Finds
PHILADELPHIA (February 15, 2025) — A new study presented today by researchers at Fox Chase Cancer Center shows that some patients with metastatic kidney cancer receiving a combination therapy can safely stop or pause treatment after two years if they have a good response.